Centogene N.V. (CNTG) and Evotec (EVO) Discover Promising New Molecule to Treat Gaucher Disease May 14, 2024 08:34AM
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease May 14, 2024 08:30AM
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics Jan 10, 2023 08:00AM
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases Nov 4, 2021 06:30AM
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases Nov 4, 2021 06:30AM


Oct 28, 2021 06:30AM CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
Oct 28, 2021 06:30AM CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
Oct 6, 2021 08:02AM Twist Bioscience Corporation (TWST), CENTOGENE (CNTG) to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Oct 6, 2021 08:00AM CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Oct 6, 2021 08:00AM CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Oct 6, 2021 08:00AM Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Aug 20, 2020 01:30AM CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
Aug 20, 2020 01:30AM CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease